图书简介
Cost control invariably interacts with issues of quality and health care access and thus this volume deals not simply with costs but, more importantly, with value. Both macro and micro concerns are covered, including health care reforms, the implementation and effects of policy prescriptions and the economic evaluation of new drugs and technologies.
Contents: Controlling Costs In a Changing World: Regulating health care markets, Alan Maynard; The need for change: health reforms in Turkey, Nesrin E. Çilingiroglu; Changing patterns of service delivery in NHS Wales, Siobhan E. McClelland; GP fundholder admissions and the new NHS, Shelia Ellwood; Relationships in health care commissioning: a case study of Glasgow, Moira Fischbacher and Arthur Francis; Towards more equitable resource allocation to GP practice, Xiao-Ming Huang, Jackie Green, Dick Beath and John E. Clarke; Impact of financial exclusion on health care utilization: is insurance the answer? The case of Kissidougou in rural Guinea-Conarky, Bart Criel, Moussa Sylla, Xavier de Béthune, Mohammed Lamine Yansané, Yéroboye Camara, Sékou Condé and Michel Gody; Supporting purchasing in acute specialists in the Trent region, Nick Payne, Ron Akehurst, Steve Beard, Alan Brennan, Neill Calvert, Jim Chilcott, Chris McCabe, Suzy Paisley and Sue Ward. Economic Evaluation And Its Contribution To Controlling Costs: Is Prevention better than treatment? Implementing evidence-based strategies, Ceri J. Phillips; Cost-effectiveness of alendronate for fracture prevention in postmenopausal women, Jan Jones and David A. Scott; Economic analysis relating to the use of neurological magnetic resonance imaging (MRI), Michael Clark, Ala Szczepura, John Hutton and Joy Fletcher; Evaluating telemedicine support of chronic disease management, Derek G. Cramp, Alastair Morgan, Abdul V. Roudsari and Ewart R. Carson; The cost-effectiveness of economic evaluations, Elisabeth Brock and Mo Malek; Decision analysis: purpose, pitfalls and potential, Manouche Tavakoli, Huw T.O. Davies and Richard Thomson. Concluding Remarks: Strategic issues in health care management – future challenges, Charles Normand.
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐